These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2280360)

  • 21. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths.
    Sedman AJ; Wagner JG
    J Pharmacokinet Biopharm; 1974 Apr; 2(2):149-60. PubMed ID: 4427219
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.
    Houston JB; Kenworthy KE
    Drug Metab Dispos; 2000 Mar; 28(3):246-54. PubMed ID: 10681367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of Laplace transform for the general disposition deconvolution equation in drug metabolism kinetics.
    Popović J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):409-11. PubMed ID: 10445406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the two-compartment open model with Michaelis-Menten elimination kinetics to valproic acid in the bile-exteriorized rat.
    Lawyer CH; Gerber N; Lynn RK; Dickinson RG
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):469-84. PubMed ID: 6770426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the difficulties of fitting the double Michaelis-Menten equation to kinetic data.
    Bates JH; Bates DA; Mackillop W
    J Theor Biol; 1987 Mar; 125(2):237-41. PubMed ID: 3657211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic binding and Michaelis-Menten metabolism of drugs.
    Rubin GM; Tozer TN
    J Pharm Sci; 1986 Jul; 75(7):660-3. PubMed ID: 3761165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1973 Apr; 1(2):103-21. PubMed ID: 4764425
    [No Abstract]   [Full Text] [Related]  

  • 32. A package of computer programs designed to simulate pharmacokinetic monitoring of drug therapy.
    Sullivan TJ; Wunderley DJ
    Comput Programs Biomed; 1980 Dec; 12(2-3):85-95. PubMed ID: 7249607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Steady-state characteristics and optimal dosage regimens for Michaelis-Menten elimination drugs].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):61-5. PubMed ID: 7657342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.
    Hansel SB; Morris ME
    J Pharmacokinet Biopharm; 1996 Apr; 24(2):219-43. PubMed ID: 8875348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute dose-dependent disposition studies of nicotinic acid in rats.
    Iwaki M; Ogiso T; Hayashi H; Tanino T; Benet LZ
    Drug Metab Dispos; 1996 Jul; 24(7):773-9. PubMed ID: 8818575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling fractal-like drug elimination kinetics using an interacting random-walk model.
    Marsh RE; Riauka TA
    Phys Rev E Stat Nonlin Soft Matter Phys; 2007 Mar; 75(3 Pt 1):031902. PubMed ID: 17500721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary, secondary, and tertiary metabolite kinetics.
    St-Pierre MV; Xu X; Pang KS
    J Pharmacokinet Biopharm; 1988 Oct; 16(5):493-527. PubMed ID: 3199316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2004; 29(3):205-14. PubMed ID: 15537173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mean residence time of drugs administered non-instantaneously and undergoing linear tissue distribution and reversible metabolism and linear or non-linear elimination from the central compartment.
    Cheng H
    Biopharm Drug Dispos; 1995 May; 16(4):259-67. PubMed ID: 7548775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.